Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page
- Check2 days agoChange DetectedThe page revision label has been updated from v3.5.3 to v3.5.4. This represents a new release of the page's content/code, without modifying displayed study details.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a minor update to the page's revision history. The change does not modify visible content or user-facing features.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated: v3.5.2 was added and v3.5.0 was removed.SummaryDifference0.0%

- Check59 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0, indicating a minor metadata update with no changes to study details or results.SummaryDifference0.0%

- Check67 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check95 days agoChange DetectedSite revision v3.4.2 was added and the government funding status notice from v3.4.1 was removed; no study content changes were made. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.